ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Disease Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38V7703
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Kidney Disease Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Kidney Disease Drugs Market Research Report 2025

Code: QYRE-Auto-38V7703
Report
July 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Roche
Pfizer Inc
Astrazeneca plc
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen Inc
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical

Kidney Disease Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Kidney Disease Drugs Market

Kidney Disease Drugs Market

The global market for Kidney Disease Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Disease Drugs.
The Kidney Disease Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Disease Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kidney Disease Drugs Market Report

Report Metric Details
Report Name Kidney Disease Drugs Market
CAGR 5%
Segment by Type
  • Tablets
  • Capsule
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Sanofi, Roche, Pfizer, AstraZeneca, Keryx Biopharmaceuticals, Kissei Pharmaceutical, AbbVie, Amgen, Teva Pharmaceutical Industries, Tianjin Tongrentang Group, Jiangxi Jimin Kexin Jinshuibao Pharmaceutical, Datong Liqun Pharmaceutical, Hebei Ruisen Pharmaceutical, Changxing Pharmaceutical, zhejiang Shengbokang Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Kidney Disease Drugs Market report?

Ans: The main players in the Kidney Disease Drugs Market are GlaxoSmithKline, Sanofi, Roche, Pfizer, AstraZeneca, Keryx Biopharmaceuticals, Kissei Pharmaceutical, AbbVie, Amgen, Teva Pharmaceutical Industries, Tianjin Tongrentang Group, Jiangxi Jimin Kexin Jinshuibao Pharmaceutical, Datong Liqun Pharmaceutical, Hebei Ruisen Pharmaceutical, Changxing Pharmaceutical, zhejiang Shengbokang Pharmaceutical

What are the Application segmentation covered in the Kidney Disease Drugs Market report?

Ans: The Applications covered in the Kidney Disease Drugs Market report are Chronic Glomerulonephritis, Nephrotic Syndrome, Chronic Renal Failure, Kidney Stones, Renal Cyst (polycystic Kidney), Diabetic Nephropathy, Hypertensive Nephropathy, Purpura Nephritis, Lupus Nephritis, Pediatric Kidney Disease

What are the Type segmentation covered in the Kidney Disease Drugs Market report?

Ans: The Types covered in the Kidney Disease Drugs Market report are Tablets, Capsule, Other

Recommended Reports

Kidney Disease Drugs

Cardiovascular & Hypertension

Therapeutics & Diagnostics

1 Kidney Disease Drugs Market Overview
1.1 Product Definition
1.2 Kidney Disease Drugs by Type
1.2.1 Global Kidney Disease Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Kidney Disease Drugs by Application
1.3.1 Global Kidney Disease Drugs Market Value by Application (2024 VS 2031)
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.4 Global Kidney Disease Drugs Market Size Estimates and Forecasts
1.4.1 Global Kidney Disease Drugs Revenue 2020-2031
1.4.2 Global Kidney Disease Drugs Sales 2020-2031
1.4.3 Global Kidney Disease Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Kidney Disease Drugs Market Competition by Manufacturers
2.1 Global Kidney Disease Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Kidney Disease Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Kidney Disease Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Kidney Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kidney Disease Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Disease Drugs, Product Type & Application
2.7 Global Key Manufacturers of Kidney Disease Drugs, Date of Enter into This Industry
2.8 Global Kidney Disease Drugs Market Competitive Situation and Trends
2.8.1 Global Kidney Disease Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Kidney Disease Drugs Players Market Share by Revenue
2.8.3 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kidney Disease Drugs Market Scenario by Region
3.1 Global Kidney Disease Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Kidney Disease Drugs Sales by Region: 2020-2031
3.2.1 Global Kidney Disease Drugs Sales by Region: 2020-2025
3.2.2 Global Kidney Disease Drugs Sales by Region: 2026-2031
3.3 Global Kidney Disease Drugs Revenue by Region: 2020-2031
3.3.1 Global Kidney Disease Drugs Revenue by Region: 2020-2025
3.3.2 Global Kidney Disease Drugs Revenue by Region: 2026-2031
3.4 North America Kidney Disease Drugs Market Facts & Figures by Country
3.4.1 North America Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Kidney Disease Drugs Sales by Country (2020-2031)
3.4.3 North America Kidney Disease Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Kidney Disease Drugs Market Facts & Figures by Country
3.5.1 Europe Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Kidney Disease Drugs Sales by Country (2020-2031)
3.5.3 Europe Kidney Disease Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Disease Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Kidney Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Kidney Disease Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Kidney Disease Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Kidney Disease Drugs Market Facts & Figures by Country
3.7.1 Latin America Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Kidney Disease Drugs Sales by Country (2020-2031)
3.7.3 Latin America Kidney Disease Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Disease Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Disease Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Kidney Disease Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Kidney Disease Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Disease Drugs Sales by Type (2020-2031)
4.1.1 Global Kidney Disease Drugs Sales by Type (2020-2025)
4.1.2 Global Kidney Disease Drugs Sales by Type (2026-2031)
4.1.3 Global Kidney Disease Drugs Sales Market Share by Type (2020-2031)
4.2 Global Kidney Disease Drugs Revenue by Type (2020-2031)
4.2.1 Global Kidney Disease Drugs Revenue by Type (2020-2025)
4.2.2 Global Kidney Disease Drugs Revenue by Type (2026-2031)
4.2.3 Global Kidney Disease Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Kidney Disease Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Kidney Disease Drugs Sales by Application (2020-2031)
5.1.1 Global Kidney Disease Drugs Sales by Application (2020-2025)
5.1.2 Global Kidney Disease Drugs Sales by Application (2026-2031)
5.1.3 Global Kidney Disease Drugs Sales Market Share by Application (2020-2031)
5.2 Global Kidney Disease Drugs Revenue by Application (2020-2031)
5.2.1 Global Kidney Disease Drugs Revenue by Application (2020-2025)
5.2.2 Global Kidney Disease Drugs Revenue by Application (2026-2031)
5.2.3 Global Kidney Disease Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Kidney Disease Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Kidney Disease Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Kidney Disease Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Kidney Disease Drugs Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Kidney Disease Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Kidney Disease Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Keryx Biopharmaceuticals
6.6.1 Keryx Biopharmaceuticals Company Information
6.6.2 Keryx Biopharmaceuticals Description and Business Overview
6.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolio
6.6.5 Keryx Biopharmaceuticals Recent Developments/Updates
6.7 Kissei Pharmaceutical
6.7.1 Kissei Pharmaceutical Company Information
6.7.2 Kissei Pharmaceutical Description and Business Overview
6.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kissei Pharmaceutical Kidney Disease Drugs Product Portfolio
6.7.5 Kissei Pharmaceutical Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Company Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AbbVie Kidney Disease Drugs Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Company Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amgen Kidney Disease Drugs Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Tianjin Tongrentang Group
6.11.1 Tianjin Tongrentang Group Company Information
6.11.2 Tianjin Tongrentang Group Description and Business Overview
6.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolio
6.11.5 Tianjin Tongrentang Group Recent Developments/Updates
6.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
6.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Information
6.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
6.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolio
6.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Developments/Updates
6.13 Datong Liqun Pharmaceutical
6.13.1 Datong Liqun Pharmaceutical Company Information
6.13.2 Datong Liqun Pharmaceutical Description and Business Overview
6.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolio
6.13.5 Datong Liqun Pharmaceutical Recent Developments/Updates
6.14 Hebei Ruisen Pharmaceutical
6.14.1 Hebei Ruisen Pharmaceutical Company Information
6.14.2 Hebei Ruisen Pharmaceutical Description and Business Overview
6.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolio
6.14.5 Hebei Ruisen Pharmaceutical Recent Developments/Updates
6.15 Changxing Pharmaceutical
6.15.1 Changxing Pharmaceutical Company Information
6.15.2 Changxing Pharmaceutical Description and Business Overview
6.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Changxing Pharmaceutical Kidney Disease Drugs Product Portfolio
6.15.5 Changxing Pharmaceutical Recent Developments/Updates
6.16 zhejiang Shengbokang Pharmaceutical
6.16.1 zhejiang Shengbokang Pharmaceutical Company Information
6.16.2 zhejiang Shengbokang Pharmaceutical Description and Business Overview
6.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolio
6.16.5 zhejiang Shengbokang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Disease Drugs Industry Chain Analysis
7.2 Kidney Disease Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Disease Drugs Production Mode & Process Analysis
7.4 Kidney Disease Drugs Sales and Marketing
7.4.1 Kidney Disease Drugs Sales Channels
7.4.2 Kidney Disease Drugs Distributors
7.5 Kidney Disease Drugs Customer Analysis
8 Kidney Disease Drugs Market Dynamics
8.1 Kidney Disease Drugs Industry Trends
8.2 Kidney Disease Drugs Market Drivers
8.3 Kidney Disease Drugs Market Challenges
8.4 Kidney Disease Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Sanofi
Roche
Pfizer Inc
Astrazeneca plc
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen Inc
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical
List of Tables
 Table 1. Global Kidney Disease Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kidney Disease Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kidney Disease Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kidney Disease Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kidney Disease Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kidney Disease Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kidney Disease Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kidney Disease Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kidney Disease Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kidney Disease Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kidney Disease Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Kidney Disease Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kidney Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Disease Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kidney Disease Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Kidney Disease Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Kidney Disease Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Kidney Disease Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kidney Disease Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kidney Disease Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kidney Disease Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Kidney Disease Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kidney Disease Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Kidney Disease Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kidney Disease Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kidney Disease Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Kidney Disease Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Kidney Disease Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kidney Disease Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kidney Disease Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Kidney Disease Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kidney Disease Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kidney Disease Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Kidney Disease Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Kidney Disease Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kidney Disease Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kidney Disease Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Kidney Disease Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Kidney Disease Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Kidney Disease Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Kidney Disease Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kidney Disease Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kidney Disease Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Kidney Disease Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Kidney Disease Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Kidney Disease Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Kidney Disease Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Kidney Disease Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Kidney Disease Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Kidney Disease Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Kidney Disease Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kidney Disease Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kidney Disease Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Kidney Disease Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Kidney Disease Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Kidney Disease Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Kidney Disease Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Kidney Disease Drugs Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Kidney Disease Drugs Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Pfizer Kidney Disease Drugs Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Kidney Disease Drugs Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Keryx Biopharmaceuticals Company Information
 Table 96. Keryx Biopharmaceuticals Description and Business Overview
 Table 97. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Keryx Biopharmaceuticals Kidney Disease Drugs Product
 Table 99. Keryx Biopharmaceuticals Recent Developments/Updates
 Table 100. Kissei Pharmaceutical Company Information
 Table 101. Kissei Pharmaceutical Description and Business Overview
 Table 102. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Kissei Pharmaceutical Kidney Disease Drugs Product
 Table 104. Kissei Pharmaceutical Recent Developments/Updates
 Table 105. AbbVie Company Information
 Table 106. AbbVie Description and Business Overview
 Table 107. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AbbVie Kidney Disease Drugs Product
 Table 109. AbbVie Recent Developments/Updates
 Table 110. Amgen Company Information
 Table 111. Amgen Description and Business Overview
 Table 112. Amgen Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Amgen Kidney Disease Drugs Product
 Table 114. Amgen Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Company Information
 Table 116. Teva Pharmaceutical Industries Description and Business Overview
 Table 117. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Industries Kidney Disease Drugs Product
 Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 120. Tianjin Tongrentang Group Company Information
 Table 121. Tianjin Tongrentang Group Description and Business Overview
 Table 122. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Tianjin Tongrentang Group Kidney Disease Drugs Product
 Table 124. Tianjin Tongrentang Group Recent Developments/Updates
 Table 125. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Information
 Table 126. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
 Table 127. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product
 Table 129. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Developments/Updates
 Table 130. Datong Liqun Pharmaceutical Company Information
 Table 131. Datong Liqun Pharmaceutical Description and Business Overview
 Table 132. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Datong Liqun Pharmaceutical Kidney Disease Drugs Product
 Table 134. Datong Liqun Pharmaceutical Recent Developments/Updates
 Table 135. Hebei Ruisen Pharmaceutical Company Information
 Table 136. Hebei Ruisen Pharmaceutical Description and Business Overview
 Table 137. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product
 Table 139. Hebei Ruisen Pharmaceutical Recent Developments/Updates
 Table 140. Changxing Pharmaceutical Company Information
 Table 141. Changxing Pharmaceutical Description and Business Overview
 Table 142. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Changxing Pharmaceutical Kidney Disease Drugs Product
 Table 144. Changxing Pharmaceutical Recent Developments/Updates
 Table 145. zhejiang Shengbokang Pharmaceutical Company Information
 Table 146. zhejiang Shengbokang Pharmaceutical Description and Business Overview
 Table 147. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product
 Table 149. zhejiang Shengbokang Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Kidney Disease Drugs Distributors List
 Table 153. Kidney Disease Drugs Customers List
 Table 154. Kidney Disease Drugs Market Trends
 Table 155. Kidney Disease Drugs Market Drivers
 Table 156. Kidney Disease Drugs Market Challenges
 Table 157. Kidney Disease Drugs Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kidney Disease Drugs
 Figure 2. Global Kidney Disease Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Disease Drugs Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Kidney Disease Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Kidney Disease Drugs Market Share by Application: 2024 & 2031
 Figure 9. Chronic Glomerulonephritis
 Figure 10. Nephrotic Syndrome
 Figure 11. Chronic Renal Failure
 Figure 12. Kidney Stones
 Figure 13. Renal Cyst (polycystic Kidney)
 Figure 14. Diabetic Nephropathy
 Figure 15. Hypertensive Nephropathy
 Figure 16. Purpura Nephritis
 Figure 17. Lupus Nephritis
 Figure 18. Global Kidney Disease Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Kidney Disease Drugs Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Kidney Disease Drugs Sales (2020-2031) & (K Units)
 Figure 21. Global Kidney Disease Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 22. Kidney Disease Drugs Report Years Considered
 Figure 23. Kidney Disease Drugs Sales Share by Manufacturers in 2024
 Figure 24. Global Kidney Disease Drugs Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Kidney Disease Drugs Players: Market Share by Revenue in Kidney Disease Drugs in 2024
 Figure 26. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Kidney Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Kidney Disease Drugs Sales Market Share by Country (2020-2031)
 Figure 29. North America Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. U.S. Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Kidney Disease Drugs Sales Market Share by Country (2020-2031)
 Figure 33. Europe Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Kidney Disease Drugs Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region (2020-2031)
 Figure 41. China Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Taiwan Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Philippines Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Latin America Kidney Disease Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Mexico Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Brazil Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Argentina Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. UAE Kidney Disease Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Kidney Disease Drugs by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Kidney Disease Drugs by Type (2020-2031)
 Figure 63. Global Kidney Disease Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Kidney Disease Drugs by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Kidney Disease Drugs by Application (2020-2031)
 Figure 66. Global Kidney Disease Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 67. Kidney Disease Drugs Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Renal Disease Treatment Market Research Report 2024
Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Drugs Market Research Report 2025
Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Complement Drug for Kidney Disease Market Research Report 2024
Polycystic Kidney Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Diagnosis Market Research Report 2025
Acute Kidney Injury Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polycystic Kidney Disease Treatment Market Research Report 2025
Global Kidney Cancer Targeted Therapy Market Research Report 2025
Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Anemia Therapeutics Market Research Report 2025
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Continuous Renal Replacement Therapy Market Research Report 2024
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acquired Cystic Kidney Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug induced Nephrotoxicity Treatment Market Research Report 2025
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions